top of page
Search

9.9.24 LVA Weekly Update

The LVA Weekly Update is now being delivered on Friday for the following week. 

This update for the week of September 9 is found at https://secure.smore.com/n/4be3r.

The Update includes essential information including performances and events. This week's update includes:

  • PSAT/NMQST extended deadline until Monday, 9/9/24

  • Vote before 9/12/24 for LVA as the best HS school in the RJ Best of Las Vegas Survey

  • School Breakfast & Lunch update

  • Student video opportunity for National Magnet Schools of American Conference

  • Parent Funding Agreement

  • Accolades - First Friday Lunchtime Celebration

  • Class of 2025, reminders, deadlines, and updates

  • Important everyday links to forms and information

  • Upcoming performances and events

Contact Susan Thornton with any questions at thorns@nv.ccsd.net.

 

ree

 
 
 

26 Comments

Nikhil Marketysers
Nikhil Marketysers
5 days ago

Emerging Markets Offering Growth Opportunities in the Schizophrenia Drugs Market


Emerging economies are becoming hotspots for growth in the Schizophrenia Drugs Market. With increasing awareness, improving healthcare infrastructure, and expanding insurance coverage, countries in Asia-Pacific and Latin America are witnessing a rise in demand for mental health treatments. Global pharma companies are targeting these regions for clinical trials and marketing of novel antipsychotics. As access improves, these markets could significantly contribute to overall industry expansion.


To know more about the report @ https://www.emergenresearch.com/industry-report/schizophrenia-drugs-market

Like
Nikhil Marketysers
Nikhil Marketysers
5 days ago

Key Players Shaping the Schizophrenia Drugs Market Landscape


The Schizophrenia Drugs Market is highly competitive, with major pharmaceutical companies like Johnson & Johnson, Otsuka, and Eli Lilly leading the charge. These players are investing heavily in novel therapies, targeting both positive and negative symptoms of schizophrenia. The increasing focus on non-dopaminergic pathways is opening up new avenues for treatment. Strategic partnerships, acquisitions, and product launches are driving the market forward, offering hope for more comprehensive care options in the near future.


To know more about the report @ https://www.emergenresearch.com/industry-report/schizophrenia-drugs-market

Like
bottom of page